AJMC® in the Press, November 19, 2021

A piece by The Business Journals cited an article published in a supplement to The American Journal of Managed Care^® (AJMC^®). The article, “Utilizing Oncology Biosimilars to Minimize the Economic Burden Associated With Cancer Treatment: Managed Care Considerations,” discussed pharmacists’ role in providing consistent messaging about biosimilars to both health care professionals and patients with cancer.

A story by BestLife referenced a study published in a supplement to AJMC^®, titled “The Economic Impact of Peanut Allergies.” The study addressed the direct and indirect costs related to peanut allergies, which affect an estimated 1.2% of the overall US population and about 2.5% of the pediatric population.